# MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

> **NCT00275210** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 2246 (actual)

## Conditions studied

- Colonic Neoplasms

## Interventions

- **DRUG:** Oxaliplatin (SR96669)

## Key facts

- **NCT ID:** NCT00275210
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** 2246 (ACTUAL)
- **Last updated:** 2009-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00275210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00275210, "MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00275210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*